Imagine being told you finally have access to life-changing treatment for ADHD, only to have it snatched away due to bureaucratic red tape and a fragmented healthcare system. This is the harsh reality for many in England, where NHS waiting lists for ADHD assessments are spiraling out of control, partly because patients are being forced to return to public care after encountering issues with private providers. But here's where it gets even more frustrating: these private clinics, often chosen through the NHS’s 'right to choose' pathway, sometimes fail to meet national standards, leaving patients in limbo.
The issue is twofold. First, private clinics may diagnose ADHD, but their assessments don’t always align with the rigorous guidelines set by the National Institute for Health and Care Excellence (NICE). Second, some providers lack the qualified staff needed to support ongoing treatment, such as prescribing medication. This leaves patients vulnerable, like the man whose GP abruptly stopped prescribing his medication after three years because the private provider was deemed ‘out of area.’ His father shared, ‘Without medication, my son struggles to focus at work, manage daily tasks, and experiences overwhelming anxiety. His consultant warned of ‘predictable harms’ if treatment stops.’
And this is the part most people miss: the financial burden on patients can be staggering. Some are forced to pay over £200 a month for prescriptions after their GPs withdraw from shared care agreements. Meanwhile, NHS trusts like the Midlands Partnership University NHS Foundation Trust (MPFT) are overwhelmed, admitting in a letter to The Guardian that the influx of patients returning from private care is exacerbating long waiting lists and reducing their ability to handle new, complex cases.
The controversy doesn’t end there. The NHS is overspending £164 million annually on ADHD services, with a growing chunk going to poorly regulated private assessments. Demand for ADHD assessments has skyrocketed as awareness of the condition grows, leaving NHS services stretched thin—over 500,000 people are currently waiting for an assessment. Health Secretary Wes Streeting recently acknowledged the government’s struggle to manage referrals for ADHD and autism, but solutions remain elusive.
To cope, the NHS is outsourcing assessments and treatment to private providers, often through the ‘right to choose’ pathway. However, this system is fragmented and lacks clear clinical standards. For instance, one patient’s shared care agreement was withdrawn after years of treatment because their chosen private provider could diagnose ADHD but couldn’t prescribe medication. MPFT’s letter highlighted the limitations of this system, stating, ‘There is limited regulation surrounding private ADHD providers, and this case underscores the challenges we often encounter.’
Local integrated care boards are attempting to address these issues by introducing vetting services for private providers, but the question remains: Is the ‘right to choose’ pathway truly serving patients, or is it creating more problems than it solves?
This situation raises critical questions: Should private ADHD providers be held to stricter standards? How can the NHS ensure continuity of care for patients transitioning between public and private services? And what responsibility does the government bear in addressing these systemic failures?
We’d love to hear your thoughts. Do you think the current system is fair to patients? Or is it time for a complete overhaul? Share your opinions in the comments below—let’s spark a conversation that could drive real change.
